(Q85751859)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25305001%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

title

Chemotherapeutic efficacy of thioridazine as an adjunct drug in a murine model of latent tuberculosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25305001%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

1 reference

1 reference

Amandeep Singh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25305001%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Sadhna Sharma

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25305001%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

26 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25305001%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25305001%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25305001%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25305001%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

695-700

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25305001%20AND%20SRC:MED&resulttype=core&format=json

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

21 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

A fresh look at the mechanism of isoniazid-induced hepatotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

Impact of treatment completion, intolerance and adverse events on health system costs in a randomised trial of 4 months rifampin or 9 months isoniazid for latent TB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

Latent TB infection treatment acceptance and completion in the United States and Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

Comparative in vitro activity of phenothiazines against multidrug-resistant Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

The antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

Interactions of phenothiazines with lipid bilayer and their role in multidrug resistance reversal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

A Mycobacterium tuberculosis sigma factor network responds to cell-envelope damage by the promising anti-mycobacterial thioridazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

Photosensitization of DNA strand breaks by three phenothiazine derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

Steady-state kinetics and inhibitory action of antitubercular phenothiazines on mycobacterium tuberculosis type-II NADH-menaquinone oxidoreductase (NDH-2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: potential use for initial therapy of freshly diagnosed tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

Enhancement of antibiotic activity against poly-drug resistant Mycobacterium tuberculosis by phenothiazines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

Short-course therapy with daily rifapentine in a murine model of latent tuberculosis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

Cell-wall alterations as an attribute of Mycobacterium tuberculosis in latent infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

Reduced emergence of isoniazid resistance with concurrent use of thioridazine against acute murine tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

Phenothiazines as anti-tubercular agents: mechanistic insights and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

Nitrate enhances the survival of Mycobacterium tuberculosis during inhibition of respiration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

Sterilizing activity of thioridazine in combination with the first-line regimen against acute murine tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

Thioridazine lacks bactericidal activity in an animal model of extracellular tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

Antipsychotics and the risk of sudden cardiac death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

Thioridazine: resurrection as an antimicrobial agent?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

Latent tuberculosis: is there a role for thioridazine?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now!

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

Safety and efficacy of thioridazine as salvage therapy in Indian patients with XDR-TB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.08.016

10.1016/J.TUBE.2014.08.016

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25305001%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference